The Delhi High Court on Friday allowing relief to the Sun Pharma Laboratories Ltd. directed the BDR Pharmaceuticals International Pvt. Ltd. restricting them from using trademark LULIBET or any other mark that is phonetically, structurally or visually similar to the plaintiff’s trademark LABEBET.